HOPKINTON, Mass., July 29, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced that its presentation at the Leerink Swann Life Science Tools & Diagnostics Roundtable, will be webcast on August 3, at 3:00 p.m. EDT. Kevin Hrusovsky, President and CEO of Caliper, will be providing an update on the company's business and has been selected to be a panelist to discuss the rapidly growing next generation sequencing market. The live webcast can be accessed at http://wsw.com/webcast/leerink22/calp/. An archived presentation will be available for 90 days.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation and liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. For more information please visit www.caliperLS.com.
|SOURCE Caliper Life Sciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved